Gonadotropin-releasing hormone agonist-induced ovarian hyperstimulation: low-dose side effects in women and monkeys

Daniel Navot; Zev Rosenwaks; Freedolph D. Anderson; Gary D. Hodgen

doi:10.1016/s0015-0282(16)54354-4

Gonadotropin-releasing hormone agonist-induced ovarian hyperstimulation: low-dose side effects in women and monkeys

Daniel Navot, Zev Rosenwaks, Freedolph D. Anderson, Gary D. Hodgen

In: Fertility and Sterility · 1991 · vol. 55(6) , pp. 1069–1075 · doi:10.1016/s0015-0282(16)54354-4 · PMID:1828042 · W2341905489

article OA: closed CC0 ⤵ 1 in-corpus citation

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (24)

Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
Gonadotropin-Releasing Hormone Agonist Suppresses Ovulation, Menses, and Endometriosis in Monkeys: An Individualized, Intermittent Regimen* via openalex
Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex
“MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS. via openalex
The value of in vitro fertilization for the treatment of unexplained infertility via openalex
Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin) via openalex
doi:10.1007/bf01135679 via openalex
doi:10.1016/0002-9378(85)90554-x via openalex
doi:10.1016/s0015-0282(16)60615-5 via openalex
doi:10.1007/978-94-009-5588-2_18 via openalex
doi:10.1210/jcem-52-2-370 via openalex
doi:10.1007/978-94-009-5588-2_19 via openalex
doi:10.1097/00006254-198905000-00001 via openalex
doi:10.1016/s0015-0282(16)60493-4 via openalex
W6603844359 via openalex
W6626684215 via openalex
doi:10.1016/s0015-0282(16)54018-7 via openalex
doi:10.1016/s0015-0282(16)60135-8 via openalex
doi:10.1016/s0015-0282(16)60121-8 via openalex
doi:10.1016/s0015-0282(16)60077-8 via openalex
doi:10.1016/s0015-0282(16)60486-7 via openalex
doi:10.1016/0010-7824(89)90064-4 via openalex
doi:10.1016/s0015-0282(16)59763-5 via openalex
doi:10.1016/s0039-128x(78)80012-9 via openalex

Cited by (1)

A preliminary study on reduced dose (33 or 25 μg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing<i>in vitro</i>fertilization–embryo transfer 2005

Source provenance

openalex: last seen: 2026-05-14T06:19:26.718892+00:00

License: CC0 · commercial use OK

[1] Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex

[2] Gonadotropin-Releasing Hormone Agonist Suppresses Ovulation, Menses, and Endometriosis in Monkeys: An Individualized, Intermittent Regimen* via openalex

[3] Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex

[4] “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS. via openalex

[5] The value of in vitro fertilization for the treatment of unexplained infertility via openalex

[6] Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin) via openalex

[7] doi:10.1007/bf01135679 via openalex

[8] doi:10.1016/0002-9378(85)90554-x via openalex

[9] doi:10.1016/s0015-0282(16)60615-5 via openalex

[10] doi:10.1007/978-94-009-5588-2_18 via openalex

[11] doi:10.1210/jcem-52-2-370 via openalex

[12] doi:10.1007/978-94-009-5588-2_19 via openalex

[13] doi:10.1097/00006254-198905000-00001 via openalex

[14] doi:10.1016/s0015-0282(16)60493-4 via openalex

[15] W6603844359 via openalex

[16] W6626684215 via openalex

[17] doi:10.1016/s0015-0282(16)54018-7 via openalex

[18] doi:10.1016/s0015-0282(16)60135-8 via openalex

[19] doi:10.1016/s0015-0282(16)60121-8 via openalex

[20] doi:10.1016/s0015-0282(16)60077-8 via openalex

[21] doi:10.1016/s0015-0282(16)60486-7 via openalex

[22] doi:10.1016/0010-7824(89)90064-4 via openalex

[23] doi:10.1016/s0015-0282(16)59763-5 via openalex

[24] doi:10.1016/s0039-128x(78)80012-9 via openalex